Für weitere Informationen zu aktuellen Kunden, die für eine Akquisition zur Verfügung stehen, wenden Sie sich bitte an Karl-Ludwig Diehl, +49 69 710 455 472 – firstname.lastname@example.org oder füllen Sie dieses formular aus.Alle
The Company is the only privately-held supplier of e-cigarettes and vaping products among the top 10 brands in the U.S. The brand offers consumers a simple and satisfying, value-based alternative to competing e-cigarettes. The Company’s success is driven in part by its focus on its high quality products at a value price point to core Tobacco users. The brand’s ability to compete on price and product performance has fueled its C-store leadership position in volume-per-location as compared with competitors.
Revenue is on track to increase 19% in 2018 and expected to grow 54% in 2019 due to enthusiastic consumer response to the Company’s new product line launched in June of this year. As of July 2018, demand for the new product line has outpaced its supply in the limited markets where it was made available for retail sale. Management expects 25,000 units of these new products will be sold in 2018.
The Company produces precision components for a variety of end-products including medical equipment and diagnostic devices, filtration and fire suppression systems for aerospace, firearm components, fiber optic tools, and many others. The Company is well-positioned to grow its medical device business even further.
The Company serves regional and global manufacturers across the U.S. with capabilities ranging from prototyping to production, CNC milling, CNC turning, CNC swiss turning, fabrication and assembly. Management has focused on building a first-class business structure to facilitate growth and manufacture superior-quality products. Over the life of the Company, management has continually invested in new machinery and equipment upgrades to meet growing demand, in addition to developing new services and adding capabilities.
The Company operates with 44 employees from a 50,000-square-foot, state-of-the-art facility. There is about 8,000 square feet available in which to add new equipment and capacity in personnel and infrastructure. The principals, who all have operational responsibilities, as well as the Company’s senior management team, are prepared to work with a new owner to grow the business to its full potential.
This is a remarkably efficient and lean operation with only 11 employees in addition to the two active partners. Both partners are amenable to continue working at the Company indefinitely, or as long as necessary to ensure a smooth transition and transfer of know-how.
The Company’s revenues are derived from physical medicine, family practice and expert testimony. Each line of business cross-refers patients creating an end-to-end experience and one-stop shop for patients. The Company’s treatment and business model is based on close coordination among a group of medical professionals including physicians, chiropractors, physical therapists, massage therapists and physical therapy assistants. In addition, the Company operates a full-service pharmacy as well as a durable medical equipment department. The model ensures the delivery of high-quality medical care and also results in operational and billing efficiencies. In 2017, there were nearly 41,000 patient visits.
Near-term expansion opportunities include extending the portfolio of medical services, expanding Cash-based aesthetic procedures, opening new offices and rolling out off-site care programs. Competition is weak, as other providers specialize in only one or two of the domains covered by the Company. In general, competitors do not offer the same degree of comprehensive services, and hospital systems offer less personalized and often inferior patient care.
The Company has built a respected service-delivery ecosystem and a roster of marquis customers. In addition to storing and transporting sets for productions, the Company builds sets, props and stages, and delivers them anywhere they are needed. The top 10 customers have been active for an average of 10 years, and there is a well-diversified customer base with no concentration.
With decades of experience in the entertainment industry delivering time-sensitive projects within high-pressure environments, the Company is able to retain repeat customers such as Disney, NBC Universal, ABC, Nickelodeon and Activision. Management believes there is no trucking or storage company that has the size, ability or capacity to accommodate the size and sheer volume of projects that the Company regularly handles.
The Company has only begun to realize its potential to become the dominant player in a growing industry. By leveraging its unique set of capabilities in producing and managing large amounts of theatrical assets, the Company could increase its reach geographically as well as into gaming, theme parks and corporate TV and commercials.
The Company sources and distributes clinical trial, biologic and specialty drugs to pharmaceutical and biotech companies. Its customer base consists of about 285 major companies in the U.S. and abroad in the branded, generic, biotech and pharmaceutical industries. Customers include virtually all major generic drug manufacturers.
The Company has a distinct competitive advantage in a segment where customer confidentiality is key and multiple lots with different expiration dates are required to successfully perform clinical trials. Its 15 vendors have access to manifold suppliers of their own, including distributors, specialty pharmacy relationships and wholesalers. The supply chain can source as far down as the retail level, with access to almost 500 drug depots/pharmacies if necessary.